Thermo Fisher Corp (TMO) - Market Capitalization to Book Value Ratio

Corporate company logo of Thermo Scientific (TMO)

Thermo Fisher Scientific (TMO) is a recognized benchmark in diagnostics trusted by the world's leading clinics. Changes in the price-to-book multiple reflect asset valuation dynamics, where the value 5.02 represents the current metric. Long-term supply agreements for consumables ensure a stable cash flow. The business's resilience is supported by its own manufacturing plants in Europe and the US, which are critically important for global science.

Thermo Scientific (TMO) - Market Capitalization to Book Value Ratio from 07/04/2022 to 10/30/2026
Manufactured product of Thermo Fisher Corp

Geopolitical tensions and sanction restrictions are narrowing the sales markets for Thermo Fisher Scientific (TMO) high-tech equipment, creating risks for its capitalization. By analyzing changes in the market-to-book ratio, an investor assesses the premium of the market price over net assets, which allows for the timely recognition of unjustified emotional overheating of the asset and prevents overpaying for short-term impulses.

Competitors of Thermo Fisher Scientific (TMO)

ABT: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio GEHC|MTD (Mettler Toledo) - Market Capitalization to Book Value Ratio|Waters Corp (WAT) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio TECH|Market Capitalization to Book Value Ratio Bruker BioSpin (BRKR)|Market Capitalization to Book Value Ratio AZTA (Azenta, Inc.)|Market Value to Equity Ratio vareximaging.com|SMLR - Market Value to Book Value Ratio|BFLY (Butterfly Network Inc) - Capitalization to Book Value Ratio|Mesa Labs Corp (MLAB) - Market Value to Book Value Ratio|Market-to-Book Ratio Quantum-Si Corporation (QSI)|Market Value to Book Value Ratio Nano-X Imaging Ltd.|quanterix.com (QTRX) - Market Capitalization to Book Value|Market Cap to Net Assets Ratio MASS (908 Devices)|Market Cap to Book Value Multiple CV|Market Capitalization to Book Value Ratio MXCT (MaxCyte, Inc)|Market Capitalization to Book Value Rapid Micro Biosystems Inc. (RPID)|Seer, Inc. - Market Capitalization to Book Value Ratio|hyperfine.io (HYPR) - Market Cap to Net Assets Ratio|FONR (FONAR) - Market Cap to Net Assets Ratio|Daxor - Market Value to Book Value|Market Value to Book Value Ratio Spectral AI, Inc.|Market Cap to Net Assets Ratio organovo.com (VIVS)|Market Capitalization to Book Value Ratio ACON|AKYA - Market-to-Book Ratio|Market Capitalization to Book Value Ratio THMO (ThermoGenesis Holdings)|TLIS: Capitalization to Book Value Ratio|T2 Biosystems, Inc - Market Capitalization to Book Value Ratio